This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FF21101

Fujifilm Holdings Corp.

Drug Names(s): FF-21101, FF 21101

Description: FF-21101(90Y) is a combination agent containing a monoclonal antibody against P-cadherin radiolabeled with Yttrium-90 (90Y). FF-21101(90Y) inhibits the growth of P-cadherin-expressing solid tumor cancers and, conjugated with the radionuclide, is expected to be more effective than an antibody therapy targeted to P-cadherin alone.


FF21101 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug